Gelson WT - Search Results

1

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis.

Foster GR, Irving WL, Cheung MC, Walker AJ, Hudson BE, Verma S, McLauchlan J, Mutimer DJ, Brown A, Gelson WT, MacDonald DC, Agarwal K; HCV Research, UK. Foster GR, et al. Among authors: gelson wt. J Hepatol. 2016 Jun;64(6):1224-31. doi: 10.1016/j.jhep.2016.01.029. Epub 2016 Jan 30. J Hepatol. 2016. PMID: 26829205

2

Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection.

Hoare M, Gelson WT, Rushbrook SM, Curran MD, Woodall T, Coleman N, Davies SE, Alexander GJ. Hoare M, et al. Among authors: gelson wt. Hepatology. 2008 Dec;48(6):1737-45. doi: 10.1002/hep.22484. Hepatology. 2008. PMID: 18925639 Free PMC article.

3

CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection.

Hoare M, Gelson WT, Das A, Fletcher JM, Davies SE, Curran MD, Vowler SL, Maini MK, Akbar AN, Alexander GJ. Hoare M, et al. Among authors: gelson wt. J Hepatol. 2010 Aug;53(2):252-60. doi: 10.1016/j.jhep.2010.03.005. Epub 2010 Apr 22. J Hepatol. 2010. PMID: 20462651 Free PMC article.

4

γ-H2AX+CD8+ T lymphocytes cannot respond to IFN-α, IL-2 or IL-6 in chronic hepatitis C virus infection.

Hoare M, Shankar A, Shah M, Rushbrook S, Gelson W, Davies S, Akbar A, Alexander GJ. Hoare M, et al. J Hepatol. 2013 May;58(5):868-74. doi: 10.1016/j.jhep.2012.12.009. Epub 2012 Dec 17. J Hepatol. 2013. PMID: 23257612 Free PMC article.

5

Hepatic sarcoidosis complicating treatment-naive viral hepatitis.

Aravinthan A, Gelson W, Limbu A, Brais R, Richardson P. Aravinthan A, et al. World J Hepatol. 2012 Dec 27;4(12):402-5. doi: 10.4254/wjh.v4.i12.402. World J Hepatol. 2012. PMID: 23355920 Free PMC article.

6

Beta-blockers in cirrhosis patients with refractory ascites.

Robins A, Bowden A, Watson W, Smith F, Gelson W, Griffiths W. Robins A, et al. Hepatology. 2014 May;59(5):2054-5. doi: 10.1002/hep.26676. Epub 2014 Mar 24. Hepatology. 2014. PMID: 23929786 No abstract available.

7

Pi*Z heterozygous alpha-1 antitrypsin states accelerate parenchymal but not biliary cirrhosis.

Cacciottolo TM, Gelson WT, Maguire G, Davies SE, Griffiths WJ. Cacciottolo TM, et al. Among authors: gelson wt. Eur J Gastroenterol Hepatol. 2014 Apr;26(4):412-7. doi: 10.1097/MEG.0000000000000061. Eur J Gastroenterol Hepatol. 2014. PMID: 24518491

8

Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis.

Cheung MCM, Walker AJ, Hudson BE, Verma S, McLauchlan J, Mutimer DJ, Brown A, Gelson WTH, MacDonald DC, Agarwal K, Foster GR, Irving WL; HCV Research UK. Cheung MCM, et al. Among authors: gelson wth. J Hepatol. 2016 Oct;65(4):741-747. doi: 10.1016/j.jhep.2016.06.019. Epub 2016 Jul 5. J Hepatol. 2016. PMID: 27388925 Free article.

9

Cohort Profile: The Hepatitis C Virus (HCV) Research UK Clinical Database and Biobank.

McLauchlan J, Innes H, Dillon JF, Foster G, Holtham E, McDonald S, Wilkes B, Hutchinson SJ, Irving WL; HCV Research UK Steering Committee. McLauchlan J, et al. Int J Epidemiol. 2017 Oct 1;46(5):1391-1391h. doi: 10.1093/ije/dyw362. Int J Epidemiol. 2017. PMID: 28338838 Free PMC article. No abstract available.

10

Is elimination of hepatitis C from the UK by 2030 a realistic goal?

Gelson W, Alexander G. Gelson W, et al. Br Med Bull. 2017 Sep 1;123(1):59-67. doi: 10.1093/bmb/ldx017. Br Med Bull. 2017. PMID: 28605444 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters